3pk Ibuprofen Lysine
Ibuprofen Lysine Solution
Product Images NDC 66993-490
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ibuprofen Lysine (NDC 66993-490). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Table 1 (Table 1)
The text provides a table listing adverse events within 30 days of therapy in a multicenter study. The table shows the percentage incidence of each adverse event for Ibuprofen Lysine and Placebo. The adverse events include sepsis, anemia, total bleeding, intraventricular hemorrhage, respiratory infection, skin lesion/irritation, and more. The table clarifies that given subjects may have experienced more than one specific event within these adverse event categories. Only the most severe grade of IVH counted for a given subject.*
Structural Formula (Structuralformula)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
